Nasus Pharma NSRX
NYSE NSRX
$3.40 +0.16 (+4.65%)
As of: Oct 21, 2026 · 11:35 AM EDT

Nasus Pharma (NSRX) Non-Current Assets (2024 - 2026)

Updated

Nasus Pharma's Non-Current Assets came in at $138,000 for Q2 2026, down 60.3% from $348,000 a year earlier.

Analysis

Nasus Pharma (NSRX) Non-Current Assets (2024 - 2026) Analysis & Trends

At the end of FY2025, Nasus Pharma's Non-Current Assets was $149,000, down 42.7% from FY2024.

  • Going back by year, Non-Current Assets was $260,000 in FY2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Eli Lilly 1,130.22 Bn 1,098.81 Bn 19.71 Bn 77.61 Bn
2 Johnson & Johnson 613.62 Bn 532.15 Bn 17.26 Bn 141.29 Bn
3 AbbVie 501.46 Bn 474.57 Bn 12.70 Bn 101.45 Bn
4 Merck 366.84 Bn 321.22 Bn 12.21 Bn 125.00 Mn
5 Novartis Ag 297.85 Bn 261.84 Bn 11.24 Bn 94.68 Bn
6 Astrazeneca 261.66 Bn 235.34 Bn 12.86 Bn 87.87 Bn
7 Amgen 235.39 Bn 190.79 Bn 7.24 Bn 60.68 Bn
8 Gilead Sciences 190.66 Bn 164.86 Bn 6.22 Bn 35.42 Bn
9 Pfizer 169.57 Bn 116.22 Bn 10.94 Bn 159.77 Bn
10 Nasus Pharma 27.23 Mn 10.53 Mn - 138,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 138,000.00
Dec 31, 2025 149,000.00
Jun 30, 2025 348,000.00
Dec 31, 2024 260,000.00
API Access

Nasus Pharma Non-Current Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-assets&ticker=NSRX&period=max&api_key=YOUR_API_KEY